Target intelligence / Profile preview

ATP synthase complex subunit

Molecular classification
Enzyme, Transporter (proton transporter), Molecular motor
01

Overview

The **ATP synthase complex** is a large multi-subunit enzyme embedded in the inner mitochondrial membrane of eukaryotes and the plasma or thylakoid membranes of prokaryotes and chloroplasts. It consists of two main sectors: **F1 sector:** A hydrophilic catalytic domain protruding into the mitochondrial matrix. It contains three α and three β subunits arranged alternately in a hexameric ring; β subunits contain the catalytic sites for ATP synthesis/hydrolysis. The γ, δ, ε subunits form part of a central stalk that rotates within this ring during catalysis. **FO sector:** A hydrophobic membrane-bound domain composed mainly of c-ring oligomers and an a-subunit forming proton channels. The flow of protons down their electrochemical gradient through FO drives rotation of the c-ring and attached central stalk. This rotary mechanism couples proton movement to conformational changes in F1 that catalyze ADP phosphorylation to generate most cellular ATP. The peripheral stalk stabilizes the complex against torque generated by rotation. As **Complex V** in oxidative phosphorylation, it is essential for life—mutations or inhibition cause severe bioenergetic defects such as Leigh syndrome. Some antibiotics selectively target bacterial/parasite forms as antimicrobials without affecting human enzyme function. In summary, **ATP synthase complex subunits** are critical enzymatic components responsible for cellular energy production via chemiosmotic coupling between electron transport-driven proton gradients and ADP phosphorylation.

Other names
F1FO ATP synthaseComplex VF-ATPasemitochondrial ATP synthaseH+-transporting two-sector ATPase
02

Mechanism of action

Inhibition of proton translocation through FO subunit blocks rotation and halts ATP synthesis

03

Biological functions

Cellular energy production (ATP synthesis)Proton translocation across membranesMaintenance of mitochondrial membrane potential
04

Disease associations

Mitochondrial disorders (e.g., Leigh disease)Neurodegenerative diseasesMetabolic syndromesCancer (altered energy metabolism in tumor cells)Infection (target for antimicrobial agents)
05

Safety considerations

Systemic inhibition leads to cellular energy failure and toxicity due to essential role in all eukaryotic cells
06

Interacting drugs

Oligomycin

1 more in the full profile.

Beyond the preview

Go deeper on ATP synthase complex subunit.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ATP synthase complex subunit.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call